Cowen Inc. announced that Tyler Van Buren has joined the Company's equity research team to further expand the firm's coverage of the biotechnology sector. He will be based in New York and will report to Robert Fagin, Cowen's Head of Research. Prior to joining Cowen, Mr. Van Buren was a Managing Director and senior biotechnology equity research analyst at Piper Sandler.

Prior to Piper Sandler, Mr. Van Buren spent five years on the biopharma research team at Cowen.